Literature DB >> 21050256

The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-hydroxyvitamin D3 in human hypertension.

Anand Vaidya1, Luminita Pojoga, Patricia C Underwood, John P Forman, Paul N Hopkins, Gordon H Williams, Jonathan S Williams.   

Abstract

OBJECTIVE: Both resistin and vitamin D have been associated with the renin-angiotensin-aldosterone system (RAAS). We investigated the association between resistin and the RAAS, and resistin and vitamin D under controlled dietary sodium conditions.
DESIGN: Retrospective cross-sectional study of subjects from the HyperPATH Consortium, who were maintained in high dietary sodium (HS) and low dietary sodium (LS) balance for 1 week each. PATIENTS: Caucasian subjects with hypertension (n=177). MEASUREMENTS: 25-Hydroxyvitamin D (25[OH]D) levels were used to assess vitamin D status. Plasma resistin and RAAS measures were evaluated on each dietary intervention.
RESULTS: Resistin levels were significantly higher in LS, where RAAS activity was high, when compared with HS balance, where RAAS activity was suppressed (6.36 vs 5.86 μg/l, P < 0.0001); however, resistin concentrations were not associated with plasma renin activity or serum aldosterone on either diet. 25(OH)D levels were positively and independently associated with resistin in both dietary conditions (HS: β=0.400, P-trend=0.027; LS: β=0.540, P-trend=0.014).
CONCLUSIONS: Dietary sodium loading reduced resistin levels, possibly by suppressing the RAAS; however, circulating RAAS components were not related to resistin concentrations within each specific dietary sodium condition. 25(OH)D was positively associated with resistin and may be involved in resistin regulation through an unknown mechanism. Further studies to understand resistin regulation in human hypertension better are warranted.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21050256      PMCID: PMC3059847          DOI: 10.1111/j.1365-2265.2010.03922.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  39 in total

1.  Plasma resistin levels associate with risk for hypertension among nondiabetic women.

Authors:  Luxia Zhang; Gary C Curhan; John P Forman
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Resistin, central obesity, and type 2 diabetes.

Authors:  C L McTernan; P G McTernan; A L Harte; P L Levick; A H Barnett; S Kumar
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

4.  Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.

Authors:  D B Savage; C P Sewter; E S Klenk; D G Segal; A Vidal-Puig; R V Considine; S O'Rahilly
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

5.  25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians.

Authors:  Anand Vaidya; John P Forman; Paul N Hopkins; Ellen W Seely; Jonathan S Williams
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2011-02-17       Impact factor: 1.636

6.  Comparative studies of resistin expression and phylogenomics in human and mouse.

Authors:  Rong-Ze Yang; Qing Huang; Aihua Xu; John C McLenithan; Jonathan A Eisen; Alan R Shuldiner; Serhan Alkan; Da-Wei Gong; Jonathan A Eison
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

Review 7.  Adipokines and blood pressure control.

Authors:  Frederique Yiannikouris; Manisha Gupte; Kelly Putnam; Lisa Cassis
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

8.  Resistin release by human adipose tissue explants in primary culture.

Authors:  John N Fain; Paramjeet S Cheema; Suleiman W Bahouth; M Lloyd Hiler
Journal:  Biochem Biophys Res Commun       Date:  2003-01-17       Impact factor: 3.575

9.  Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men.

Authors:  A Titia Lely; Jan A Krikken; Stephan J L Bakker; Frans Boomsma; Robin P F Dullaart; Bruce H R Wolffenbuttel; Gerjan Navis
Journal:  J Clin Endocrinol Metab       Date:  2007-03-06       Impact factor: 5.958

10.  The adipose renin-angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal renin-angiotensin system.

Authors:  Suyeon Kim; Morvarid Soltani-Bejnood; Annie Quignard-Boulange; Florence Massiera; Michele Teboul; Gerard Ailhaud; Jung Han Kim; Naima Moustaid-Moussa; Brynn H Voy
Journal:  J Biomed Biotechnol       Date:  2006
View more
  14 in total

1.  Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake.

Authors:  Alexander W Krug; Eric Tille; Bei Sun; Luminita Pojoga; Jonathan Williams; Bindu Chamarthi; Andrew H Lichtman; Paul N Hopkins; Gail K Adler; Gordon H Williams
Journal:  Age (Dordr)       Date:  2012-10-02

2.  Maternal vitamin D deficiency during pregnancy affects expression of adipogenic-regulating genes peroxisome proliferator-activated receptor gamma (PPARγ) and vitamin D receptor (VDR) in lean male mice offspring.

Authors:  Anthony M Belenchia; Karen L Jones; Matthew Will; David Q Beversdorf; Victoria Vieira-Potter; Cheryl S Rosenfeld; Catherine A Peterson
Journal:  Eur J Nutr       Date:  2016-12-21       Impact factor: 5.614

3.  The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes.

Authors:  Anand Vaidya; Patricia C Underwood; Justin P Annes; Bei Sun; Gordon H Williams; John P Forman; Jonathan S Williams
Journal:  Metabolism       Date:  2012-11-09       Impact factor: 8.694

4.  The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men.

Authors:  Anand Vaidya; John P Forman; Patricia C Underwood; Paul N Hopkins; Gordon H Williams; Luminita H Pojoga; Jonathan S Williams
Journal:  Eur J Endocrinol       Date:  2011-03-14       Impact factor: 6.664

Review 5.  Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney disease.

Authors:  Anand Vaidya; John P Forman
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

6.  Physical Activity and the Acute Hemodynamic Response to ACE Inhibition in Hypertension.

Authors:  Stephen A Maris; Kayla M Meyer; Gillian Murray; Jonathan S Williams
Journal:  Am J Lifestyle Med       Date:  2020-07-07

7.  Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk.

Authors:  Jenifer M Brown; Patricia C Underwood; Claudio Ferri; Paul N Hopkins; Gordon H Williams; Gail K Adler; Anand Vaidya
Journal:  Hypertension       Date:  2014-03-24       Impact factor: 10.190

8.  Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.

Authors:  Gregory L Hundemer; Rene Baudrand; Jenifer M Brown; Gary Curhan; Gordon H Williams; Anand Vaidya
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

Review 9.  Adipokines: novel players in resistant hypertension.

Authors:  Ana Paula de Faria; Rodrigo Modolo; Vanessa Fontana; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-09-04       Impact factor: 3.738

10.  Obesity, adipose tissue function and the role of vitamin D.

Authors:  Aneta U Koszowska; Justyna Nowak; Anna Dittfeld; Anna Brończyk-Puzoń; Agata Kulpok; Barbara Zubelewicz-Szkodzińska
Journal:  Cent Eur J Immunol       Date:  2014-06-27       Impact factor: 2.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.